Skip to content
  • Home
  • Subscribe to email list

Pharminent

  • Home
  • Subscribe to email list
Cancer, Immunotherapy July 7, 2017July 22, 2017

Celgene joins PD-1 race via partnership with BeiGene

The pharma giant will pay the Chinese firm up to $980m in milestone payments http://www.pmlive.com/pharma_news/celgene_joins_pd-1_race_via_partnership_with_beigene_1197746

Post navigation

← Previous Post

Novartis’ psoriasis drug gets label boost

Next Post →

Alnylam Buckles Down On A Belt Of Rare Diseases

Categories
RSS Emerging Markets
  • Chinese R&D sector takes ‘significant step’ as outsourcing demand increases December 7, 2017
  • Six factors shaping healthcare in emerging markets October 10, 2017
  • How Startups Are Trying To Overcome India’s Healthcare Challenges September 25, 2017
  • Trovagene Announces Agreement with Novogene for NextCollect™ in China July 12, 2017
  • China FDA changes will speed up approval process, says CRO June 7, 2017
  • India’s drugmakers need more time to meet international standards: industry group May 17, 2017
  • Generic consistency evaluation in China: the coming paradigm shift in drug pricing and patent cliff April 19, 2017
RSS Biosimilar
  • AbbVie, Samsung Bioepis in deal; Humira biosimilar U.S. release in 2023 April 5, 2018
  • Mundipharma inks third biosimilar deal with Celltrion March 21, 2018
  • Industry touts savings potential of generics and biosimilars February 14, 2018
  • Biogen looking to up its stake in Samsung biosimilar JV February 1, 2018
  • Sandoz announces exclusive global collaboration with Biocon on next-generation biosimilars January 18, 2018
  • Lucentis biosimilar: Formycon eyes 2020 for US launch November 28, 2017
  • Five more biosimilar-free years for AbbVie’s Humira September 28, 2017
RSS Pricing
  • Hospitals To Be Required To Post Prices Online As Part Of CMS Push To Increase Transparency April 25, 2018
  • Pricing and Market Access Outlook 2018 March 5, 2018
  • Roche hemophilia drug lowers costs despite high price: ICER January 27, 2018
  • Payers point to Spark’s gene therapy as a model for innovative pricing plans January 12, 2018
  • FDA eyes even more pricing competition with another round of generics moves November 14, 2017
  • New Infographic: A Response to “A Better Deal” on Drug Pricing September 21, 2017
  • On Drug Pricing: FDA Backs Up Its Calls for Increased Competition August 21, 2017
RSS Payer
  • How Pharma Can Help Patients Feel Less Overwhelmed When Dealing with Payers April 20, 2018
  • Perspectives: CMS Takes Steps to Ensure Patients Benefit From Negotiated Discounts February 7, 2018
  • CMS Considers Alternate Payment Models To Curb Costs On High-Price Treatments, Gene Therapy December 1, 2017
  • Novartis’ CAR-T drug needs new payment model, says Express Scripts September 25, 2017
  • Op-Ed: Why single-payer health-care could be closer than you think June 26, 2017
RSS Marketing
  • AstraZeneca at Cannes: Healthcare delivery’s speeding away from pharma’s marketing model June 26, 2017
  • What marketers need to know about tax reform, off-label promotion, pricing May 17, 2017
  • The Impact of AI and Machine Learning in Marketing February 27, 2017
RSS R&D
  • Creating a connected ecosystem to gain insights across R&D May 15, 2018
  • Commercial Trends Forecast: ‘R&D is transforming into R&D&C’ March 13, 2018
  • Eliminating Silos: Dismantling the Frankenstein of Clinical R&D March 5, 2018
RSS Company News
  • Novartis forges forward into digital pharma with FocalView app April 25, 2018
  • Sandoz, Pear to commercialize prescription digital therapeutics April 19, 2018
  • As Novartis Buys Into Gene Therapy, GSK Bows Out With Orchard Deal April 12, 2018
  • AstraZeneca licenses Ionis’ clinical-phase antisense NASH drug April 9, 2018
  • Novartis scaling ‘site-less’ trials through expanded Science 37 alliance March 7, 2018
  • AstraZeneca spins out new biotech, shedding autoimmune drugs February 28, 2018
  • Alphabet-backed Flatiron Health is being acquired by Roche February 15, 2018
RSS Immunotherapy
  • Janssen to Acquire BeneVir Biopharm to Advance Immunotherapy Regimens May 2, 2018
  • MSD’s Keytruda bags another trial success in NSCLC April 10, 2018
  • FDA Expands Bristol-Myers Squibb’s Opdivo Dosing Schedule March 6, 2018
  • BMS, Nektar to jointly develop, commercialise immunotherapy combo February 15, 2018
  • ASH 2017: CAR-T therapy and beyond December 6, 2017
  • 4 Ways To Market CAR-T Therapies October 16, 2017
  • AstraZeneca, NewLink pen PD-L1 and IDO combination pact September 25, 2017
RSS Cardiovascular
  • Regeneron/Sanofi to cut price of heart drug in Express Scripts deal May 1, 2018
  • Amgen gets prevention claim for cholesterol drug Repatha December 4, 2017
  • AstraZeneca outlicenses Brilinta reversal agent November 28, 2017
  • EU OKs low-dose Xarelto to prevent recurrent VTE November 2, 2017
  • AstraZeneca touts Brilinta CV benefit with new analysis August 24, 2017
  • Merck, Novartis pipeline stunners headline surprisingly good month for CV agents June 28, 2017
  • Novartis heart drug success opens up new care option June 22, 2017
RSS Diabetes
  • Software That Uses Artificial Intelligence To Screen Eyes For Diabetes Damage Approved By FDA April 13, 2018
  • Boehringer Ingelheim and Lilly expand heart failure program for Jardiance® with new exercise capacity trials March 6, 2018
  • Boehringer strikes Jardiance outcomes deal with Prime PBM January 31, 2018
  • Lilly partners with Rimidi on digital diabetes management tool December 15, 2017
  • One Drop and Fitbit to integrate diabetes and activity data November 1, 2017
  • Fitbit and Dexcom to bring diabetes data to Ionic smartwatch September 8, 2017
  • Diabetes drugmakers partner with mobile startups to boost patient engagement July 20, 2017
RSS Alzheimer’s
  • AbbVie, Voyager set sights on ‘one-time’ Alzheimer’s treatment February 20, 2018
  • AbbVie, Alector to develop novel treatments for Alzheimer’s disease October 25, 2017
  • Assessing The Pipeline For Alzheimer’s Disease (Part I: Anti-Amyloid Antibodies) October 13, 2017
  • Biogen’s Alzheimer’s Hope Tops The Sector’s Most Valuable Pipeline Projects August 16, 2017
  • New Gene Discoveries Could Redefine Alzheimer’s Treatment July 21, 2017
Create a website or blog at WordPress.com